# Lung Cancer Vaccine Plus Oral Dietary Supplement

> **NCT01829373** · PHASE1 · COMPLETED · sponsor: **Edward Hirschowitz** · enrollment: 5 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** vaccine 1650-G

## Key facts

- **NCT ID:** NCT01829373
- **Lead sponsor:** Edward Hirschowitz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-06
- **Final completion:** 2013-02
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01829373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01829373, "Lung Cancer Vaccine Plus Oral Dietary Supplement". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01829373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*